PPARGC1A and Alzheimer disease: Taken together, mitochondrial respiratory chain dysfunction might be a noticeable feature of POCD, and targeted therapies using PPAR-c and PGC-1a agonists previously developed for AD treatment might yield a protective effect in POCD (Kim et al., 2007; Golpich et al., 2017).